DOCSLIB.ORG

Chadi Abdallah, M.D. Associate Member Yale University Ted Abel

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Chadi Abdallah, M.D. Associate Member Yale University Ted Abel Chadi Abdallah, M.D. Ted Abel, Ph.D. James Abelson, M.D.,Ph.D. Associate Member Fellow Member Emeritus Yale University University of Iowa, Carver College of University of Michigan Health System Medicine Anissa Abi-Dargham, M.D. Megumi Adachi, Ph.D. R. Alison Adcock, M.D.,Ph.D. Fellow Associate Member Associate Member Stony Brook University Astellas Research Institute of America Duke University LLC Nika Adham, B.Sc.,M.Sc.,Ph.D. Bryon Adinoff, M.D. Caleb Adler, M.D. Member Fellow Emeritus Member Allergan, Inc. University of Colorado Medical School University of Cincinnati College of Medicine Martin Adler, Ph.D. George Aghajanian, M.D. Bernard Agranoff, B.S.,M.D. Fellow Emeritus Fellow Emeritus Fellow Emeritus Temple University School of Medicine Yale University School of Medicine University of Michigan Susanne Ahmari, M.D.,Ph.D. Katherine Aitchison, FRCPsych,Ph.D. Howard Aizenstein, M.D.,Ph.D. Member Member Member University of Pittsburgh University of Alberta University of Pittsburgh Olusola Ajilore, M.D.,Ph.D. Schahram Akbarian, M.D.,Ph.D. Huda Akil, Ph.D. Member Member Fellow University of Illinois at Chicago Icahn School of Medicine At Mount University of Michigan Sinai Martin Alda, FRCPC,M.D. Robert Alexander, M.D. George Alexopoulos, M.D. Member Member Fellow Emeritus Dalhousie University Takeda Weill Cornell Medical College Tanya Alim, M.D. Murray Alpert, Ph.D. Larry Alphs, M.D.,Ph.D. Member Fellow Emeritus Member Howard University Newron Pharmaceuticals C. Anthony Altar, Ph.D. Susan Amara, Ph.D. Stephanie Ameis, FRCP(C),M.D.,M.Sc. Member Emeritus Fellow Associate Member Verge Genomics, Inc. & NeuroDrug National Institute of Mental Health Centre for Addiction and Mental Health Consulting Christoph Anacker, Ph.D. Susan Andersen, Ph.D. Nancy Andreasen, M.D.,Ph.D. Associate Member Fellow Fellow Columbia University McLean Hospital University of Iowa Hospitals and Clinics Ana Andreazza, Ph.D. Anne Andrews, Ph.D. Burt Angrist, M.D.,Med Associate Member Fellow Fellow Emeritus University of Toronto University of California, Los Angeles NYU School of Medicine Jules Angst, Prof. Dr. med Mark Ansorge, Ph.D. James Anthony, Ph.D.,Prof. Fellow Emeritus Associate Member Fellow Emeritus Psychiatric Hospital, University of Columbia University Michigan State University, College of Zurich Human Medicine Raymond Anton, M.D. James Appel, Ph.D. Paul Appelbaum, M.D. Fellow Emeritus Fellow Emeritus Fellow Medical University of South Carolina University of South Carolina Columbia University Victoria Arango, B.S.,Ph.D. Albert Arias, M.D.,M.S. Francesc Artigas, Prof. Dr. Fellow Emeritus Associate Member Fellow Division of Translational Research, Virginia Commonwealth University Instituto de Investigaciones Biomédicas NIMHNIH de Barcelona, CSIC-IDIBAPS-CIBERSAM Robert Asarnow, Ph.D. Marie Asberg, M.D.,Ph.D. Rebecca Ashare, Ph.D. Member Fellow Emeritus Associate Member UCLA Karolinska Institutet University of Pennsylvania Perelman School of Medicine Gary Aston-Jones, Ph.D. Nancy Ator, B.A.,M.S.,Ph.D. Efrain Azmitia, Ph.D. Fellow Member Emeritus Fellow Emeritus Brain Health Institute, Rutgers Johns Hopkins School of Medicine New York University University Ryan Bachtell, Ph.D. Rosemary Bagot, Ph.D. Ursula Bailer, M.D.,Prof. Dr. med Member Associate Member Fellow University of Colorado McGill University Medical University of Vienna, Department of Psychiatry and Psychotherapy; University of California David Baker, Ph.D. Dewleen Baker, M.D. VaishaliSan Diego, Bakshi Department, Ph.D. of Psychiatry Member Member Fellow Marquette University University of California, San Diego University of Wisconsin School of Medicine and Public Health Ross Baldessarini, M.D.,Sc.D. Tracy Bale, Ph.D. Elizabeth Ballard, Ph.D. Fellow Emeritus Member Associate Member McLean HospitalHarvard Medical University of Maryland School of National Institute of Mental Health School Medicine James Ballenger, M.D. Robert Balster, Ph.D. Darrick Balu, Ph.D. Fellow Emeritus Fellow Emeritus Associate Member Virginia Commonwealth University McLean Hospital, Harvard Medical School Thomas Ban, FRCP(C),M.D. Debra Bangasser, Ph.D. Matthew Banks, Ph.D.,Pharm.D. Fellow Emeritus Member Associate Member Temple University Virginia Commonwealth University Jay Baraban, M.D.,Ph.D. Tallie Z. Baram, M.D.,Ph.D. Deanna Barch, Ph.D. Member Emeritus Fellow Fellow Johns Hopkins University School of University of California- Irvine Washington University Medicine Jack Barchas, M.D. Samuel Barondes, M.D. Christina Barr, Ph.D. Fellow Emeritus Fellow Emeritus Fellow Weill Cornell Medical CollegeNewYork- University of California, San Francisco Laboratory of Comparative Behavioral Presbyterian Hospital Genomics, NIHNIAAA James Barrett, Ph.D. Herbert Barry, Ph.D. Raymond Bartus, Ph.D. Fellow Emeritus Member Emeritus Fellow Emeritus Drexel University College of Medicine University of Pittsburgh RTBioconsultants, Inc. Lewis Baxter, M.D. Carrie Bearden, Ph.D. Charles Beasley, M.D. Fellow Emeritus Fellow Fellow Emeritus Self-Employed University of California at Los Angeles Beasley Pharmaceutical and Biotechnology Consulting, LLC Jean-Martin Beaulieu, Ph.D. Sheryl Beck, B.S.,M.S.,Ph.D. Howard Becker, Ph.D. Member Fellow Emeritus Member University of Toronto University of Pennsylvania Perelman Medical University of South Carolina School of Medicine Jill Becker, Ph.D. Aysenil Belger, Ph.D. Alan Bellack, Ph.D. Fellow Fellow Fellow Emeritus University of Michigan University of North Carolina at Chapel University of Maryland School of Hill Medicine Robert Belmaker, M.D. Ruth Benca, M.D.,Ph.D. Francine Benes, M.D.,Ph.D. Fellow Emeritus Fellow Fellow Emeritus Ben Gurion University University of California-Irvine McLean Hospital Helene Benveniste, M.D.,Ph.D. Jack Bergman, Ph.D. Karen Berman, M.D. Member Member Emeritus Fellow Yale School of Medicine McLean Hospital National Institutes of Health Sabina Berretta, M.D. Wade Berrettini, M.D.,Ph.D. Alessandro Bertolino, M.D.,Ph.D. Fellow Fellow Emeritus Member McLean Hospital University of Pennsylvania Perelman University of Bari School of Medicine Cynthia Bethea, Ph.D. Anna Beyeler, Ph.D. Zubin Bhagwagar, D.Phil.,M.D. Fellow Emeritus Associate Member Fellow Oregon National Primate Research University of Bordeaux Alexion Pharmaceuticals Center Anindya Bhattacharya, Ph.D. Giovanni Biggio, Ph.D.,Prof. Kristin Bigos, Ph.D. Member Fellow Associate Member Janssen Research & Development, LLC University of Cagliari Johns Hopkins School of Medicine Staci Bilbo, Ph.D. Robert Bilder, Ph.D. Elisabeth Binder, M.D.,Ph.D. Member Fellow Fellow Duke University Semel Institute for Neuroscience & Max Planck Institute of Psychiatry, Human Behavior Emory University School of Medicine Garth Bissette, Ph.D. James Bjork, Ph.D. Thomas Blackburn, D.Sc.,Ph.D. Fellow Emeritus Associate Member Member Emeritus Retired Virginia Commonwealth University TPBioVentures Ltd. Jennifer Blackford, Ph.D. Barry Blackwell, M.D. Randy Blakely, Ph.D. Member Fellow Emeritus Fellow Vanderbilt University Medical Center Florida Atlantic University Brain Institute Carlos Blanco, M.D.,Ph.D. Dan Blazer, M.D.,M.P.H.,Ph.D. David Bleakman, Ph.D. Fellow Member Emeritus Member National Institute on Drug Abuse Duke University Medical Center Redpin Therapeutics Pierre Blier, M.D.,Ph.D. Michael Bloch, M.D.,M.S. Floyd Bloom, M.D. Fellow Member Fellow Emeritus University of Ottawa Institute of Yale Child Study Center The Scripps Research Institute Mental Health Research Hilary Blumberg, M.D. Laura Bohn, Ph.D. Isabelle Boileau, Ph.D. Fellow Fellow Associate Member Yale University School of Medicine The Scripps Research Institute Centre for Addiction and Mental Health Shuken Boku, M.D.,Ph.D. Carlos Bolanos-Guzman, Ph.D. Maura Boldrini, M.D.,Ph.D. Associate Member Fellow Member Kumamoto University Texas A&M University Columbia University & New York State Psychiatric Institute Pascal Bonaventure, Ph.D. Antonello Bonci, M.D.,Ph.D. Alexander Borbely, M.D. Member Fellow Fellow Emeritus Janssen Research & Development, LLC Global Institutes on Addictions University of Zurich Stephanie Borgland, Ph.D. Chad Bousman, M.P.H.,Ph.D. Charles Bowden, M.D. Associate Member Associate Member Fellow Emeritus Hotchkiss Brain Institute, University of University of Calgary The University of Texas Health Science Calgary Center At San Antonio Charles Bradberry, Ph.D. Kathleen Brady, M.D.,Ph.D. Linda Brady, Ph.D. Fellow Fellow Fellow NIHNIDA Medical University of South Carolina National Institute of Mental Health, Division of Neuroscience and Basic Behavioral Science David Braff, M.D. Theresa Branchek, Ph.D. Nicholas Brandon, M.A.,Ph.D. Fellow Emeritus Fellow Emeritus Fellow University of California at San Diego Sub Arbore Consulting Jnana Therapeutics Stephen Brannan, M.D. David Bredt, M.D.,Ph.D. George Breese, Ph.D. Member Member Fellow Emeritus Karuna Therapeutics Janssen UNC School of Medicine, Bowles Center for Alcohol Studies Alan Breier, M.D. John Breitner, M.D.,M.P.H. J. Douglas Bremner, M.D. Fellow Emeritus Fellow Emeritus Member Indiana University School of Medicine McGill University Faculty of Medicine Emory University School of Medicine Heather Brenhouse, Ph.D. Kristen Brennand, Ph.D. David Brent, M.D.,M.S. Associate Member Member Member Emeritus Northeastern University Icahn School of Medicine at Mount Western Psychiatric Institute & Clinic Sinai Lisa Briand, Ph.D. Jennifer Britton, Ph.D. Arthur Brody, M.D. Associate Member Member Fellow Temple University University of Miami University of California, San Diego Melissa Brotman, Ph.D. Alan Brown, M.D.,M.P.H.
Load more

Recommended publications
  • Pharmacology and Toxicology of Amphetamine and Related Designer Drugs
    Pharmacology and Toxicology of Amphetamine and Related Designer Drugs U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES • Public Health Service • Alcohol Drug Abuse and Mental Health Administration Pharmacology and Toxicology of Amphetamine and Related Designer Drugs Editors: Khursheed Asghar, Ph.D. Division of Preclinical Research National Institute on Drug Abuse Errol De Souza, Ph.D. Addiction Research Center National Institute on Drug Abuse NIDA Research Monograph 94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Alcohol, Drug Abuse, and Mental Health Administration National Institute on Drug Abuse 5600 Fishers Lane Rockville, MD 20857 For sale by the Superintendent of Documents, U.S. Government Printing Office Washington, DC 20402 Pharmacology and Toxicology of Amphetamine and Related Designer Drugs ACKNOWLEDGMENT This monograph is based upon papers and discussion from a technical review on pharmacology and toxicology of amphetamine and related designer drugs that took place on August 2 through 4, 1988, in Bethesda, MD. The review meeting was sponsored by the Biomedical Branch, Division of Preclinical Research, and the Addiction Research Center, National Institute on Drug Abuse. COPYRIGHT STATUS The National Institute on Drug Abuse has obtained permission from the copyright holders to reproduce certain previously published material as noted in the text. Further reproduction of this copyrighted material is permitted only as part of a reprinting of the entire publication or chapter. For any other use, the copyright holder’s permission is required. All other matieral in this volume except quoted passages from copyrighted sources is in the public domain and may be used or reproduced without permission from the Institute or the authors.
    [Show full text]
  • Chadi Abdallah, M.D. Associate Member Yale University Ted Abel
    Chadi Abdallah, M.D. Ted Abel, Ph.D. James Abelson, M.D., Ph.D Associate Member Fellow Member Emeritus Yale University University of Iowa University of Michigan Elizabeth Abercrombie, Ph.D. Anissa Abi-Dargham, M.D. Megumi Adachi, Ph.D. Fellow Fellow Associate Member Rutgers University Stony Brook University Astellas Research Institute R. Alison Adcock, M.D., Ph.D Nika Adham, B.Sc., M.Sc., Ph.D. Bryon Adinoff, M.D. Associate Member Member Fellow Emeritus Duke University Allergan, Inc. University of Colorado Caleb Adler, M.D. Martin Adler, Ph.D. George Aghajanian, M.D. Member Fellow Emeritus Fellow Emeritus University of Cincinnati Temple University Yale University Bernard Agranoff, B.S., M.D. Susanne Ahmari, M.D., Ph.D Katherine Aitchison, FRCPsy, Prof. Dr. Fellow Emeritus Member med University of Michigan University of Pittsburgh Member University of Alberta Howard Aizenstein, M.D., Ph.D Olusola Ajilore, M.D., Ph.D Schahram Akbarian, M.D., Ph.D Member Member Member University of Pittsburgh University of Illinois at Chicago Icahn School of Medicine At Mount Sinai Huda Akil, Ph.D. Martin Alda, FRCPC, M.D. Robert Alexander, M.D. Fellow Member Member University of Michigan Dalhousie University Takeda George Alexopoulos, M.D. Tanya Alim, M.D. Murray Alpert, Ph.D. Fellow Emeritus Member Fellow Emeritus Weill Cornell Medical College Howard University Larry Alphs, M.D., Ph.D C. Anthony Altar, Ph.D. Susan Amara, Ph.D. Member Member Emeritus Fellow Newron Pharmaceuticals Verge Genomics, Inc National Institute of Mental Health Stephanie Ameis, FRCP(C), M.D., M.Sc. Susan Andersen, Ph.D.
    [Show full text]
  • Public Figures Affected by Pancreatic Cancer (Partial List)
    www.pancan.org | 877-272-6226 Public Figures Affected by Pancreatic Cancer (Partial List) Deceased • Hal Ashby, Academy Award-winning editor for In the Heat of the Night; director of Harold and Maude, Being There, Shampoo • Syd Barrett, singer and guitarist, Pink Floyd • Sir Alan Bates, British actor • Ralph Bates, British actor (no relation to Sir Alan Bates) • Count Basie, jazz bandleader • Melvin Belli, lawyer, “The King of Torts” • Jack Benny, comedian and actor • John Beradino, actor, best known as “Dr. Steve Hardy” on General Hospital • Myles Brand, Ph.D. – President of the National Collegiate Athletic Association (NCAA) from 2002- 2010 and prior to this position, he served as the 16th president of Indiana University • Joseph Cardinal Bernardin, Archbishop of Chicago • Steve Caldwell, singer and saxophonist • Ely Callaway, Founder, Callaway Golf • Madeleine Carroll, actress • Betty Carter, singer • Billy Carter, brother of President Jimmy Carter • James Earl Carter, Sr., father of President Jimmy Carter • Oona Chaplin, widow of Charlie Chaplin • Frank Church, U.S. Senator, Idaho • Casey Coleman, sports broadcaster • Emily Couric, Virginia state senator, sister of Katie Couric • Joan Crawford, Academy Award-winning actress • Richard Crenna, actor • George Crile III, journalist and producer, CBS • Dick Cusack, actor, patriarch of Cusack family • Chuck Daly, Hall of Fame NBA Coach • Dr. Ronald Davis, President, American Medical Association (AMA) • Richard Dean, photographer and model • Michael Deaver, Deputy White House Chief of Staff, served during President Ronald Reagan’s administration • Patrick Dennis, author, best known for “Auntie Mame” • Jacques Derrida, French philosopher and literary critic • Vince Edwards, actor • Ralph Ellison, scholar and writer, best known for “Invisible Man” • Chris Ethridge, founding member of Flying Burrito Brothers band • Art Flemming, original host, Jeopardy • Anne Francis, actress • Peggy Ann Garner, actress Pancreatic Cancer Action Network | 1500 Rosecrans Ave.
    [Show full text]
  • Alpha Omega Alpha Visiting Professorships, 2007/2008
    Alpha Omega Alpha visiting professorships, 2007/2008 University of Chicago Division of the Biological Sciences Pritzker eginning in 2002, Alpha Omega Alpha’s board of directors School of Medicine Boffered every chapter the opportunity to host a visiting Holly J. Humphrey, MD, councilor professor. Forty-nine chapters took advantage of the oppor- Michael J. Collins, MD, Hinsdale Orthopaedic Associates tunity during the 2007/2008 academic year to invite eminent INDIANA persons in American medicine to share their varied perspec- Indiana University School of Medicine tives on medicine and its practice. Aslam R. Siddiqui, MD, councilor Following are the participating chapters, their councilors, John L. Tarpley, MD, Vanderbilt University School of Medicine and their visitors. KANSAS University of Kansas School of Medicine Jeffrey M. Holzbeierlein, MD, councilor ARKANSAS University of Arkansas College of Medicine The Honorable Louis W. Sullivan, MD, Morehouse School of Anne T. Mancino, MD, councilor Medicine James Patrick O’Leary, MD, Florida State University School of LOUISIANA Medicine Louisiana State University School of Medicine in New Orleans Peter M.C. DeBlieux, MD, councilor CALIFORNIA Loma Linda University School of Medicine Louis Rice, MD, Case Western Reserve University School of Sarah M. Roddy, MD, councilor Medicine Donald Melnick, MD, National Board of Medical Examiners Louisiana State University School of Medicine in Shreveport Jeffrey German, MD, councilor DISTRICT OF COLUMBIA Stuart M. Brooks, MD, University of South Florida School of The George Washington University School of Medicine and Health Medicine Sciences Tulane University School of Medicine Alan Wasserman, MD, councilor N. Kevin Krane, MD, councilor Burton Rose, MD, Harvard Medical School Ellen Pearlman, MD, New York University School of Medicine Howard University College of Medicine Pauline Y.
    [Show full text]
  • Glioma Research Surges in the Department of Pathology and Cell
    Volume ?, Issue ? Holiday Edition 2012-2013 Glioma Research Surges This edition of The Newsletter, the 9th in the series, has a lot to cover. The last Newsletter was dedicated to the 25th anniversary of the modern era and included almost all of the recent his- in the Department of tory of the Department, as well as much that occurred many years ago. For those who did not Pathology and Cell Biology see it, it is on-line. There was no room for our usual features: Annals of Administration, New By Lloyd Greene and Peter Canoll Grants, New Faculty, New Administrators, New Residents, New Graduate Students, Promo- tions, Anniversaries, and all of the good things that help to unify a department of almost 400 There were nearly 14,000 deaths from people. This issue returns to that format and we hope to make up for lost time. We also fea- brain tumors in the US last year and for ture a short article that explains the increasing glioma research in the Department. We salute Grade IV glioblastomas (GBM), there is Carol Mason, President-elect of the Society for Neuroscience. There were two laggards for the currently no effective cure. Over the past Anniversary Newsletter-the Breast and Neuropath Services and because we are forgiving, we few years, the Department of Pathology include them here. We are back to saluting our administrators, including the HR staff and also and Cell Biology has become a vigorous Ellie Johnson our Business Manager. We admire all of the many people who got important center for brain tumor research with stud- grants in this difficult financial time.
    [Show full text]
  • Advancing Healthy Populations: the Pfizer Guide to Careers in Public Health
    public health advancing healthy populations: the pfizer guide to careers in public health advancing healthy populations: the pfizer guide to careers in public health A MUST-HAVE GUIDE THAT PROFILES THE LIFE AND WORK OF PROFESSIONALS IN PUBLIC HEALTH PFIZER INC. 235 EAST 42ND STREET NEW YORK, NY 10017-5755 XX483X00D advancing healthy populations: the pfizer guide to careers in public health A MUST-HAVE GUIDE THAT PROFILES THE LIFE AND WORK OF PROFESSIONALS IN PUBLIC HEALTH Book Editors: Barbara A. DeBuono, MD, MPH Senior Medical Director/Group Leader Public Health, Pfizer Inc. Hugh Tilson, MD, DrPH Clinical Professor of Epidemiology and Health Policy, School of Public Health, University of North Carolina The Pfizer Career Guide Series Editor: Salvatore J. Giorgianni, PharmD Director/Team Leader, External Relations Pfizer Pharmaceuticals Group, Pfizer Inc. Advancing Healthy Populations: The Pfizer Guide to Careers in Public Health Assistant Editor: Lisa Scipioni, MHS Other Pfizer Career Guide Publications: Opportunities to Care: The Pfizer Guide to Careers in Nursing Full Preparation: The Pfizer Guide to Careers in Pharmacy Embracing Your Practice: The Pfizer Guide to Careers for Physicians About the Logo: This book’s logo aims to distinguish public health occupations from others in health care. The people under the magnifying glass signify the population-based nature of public health promotion and disease detection. Advancing Healthy Populations: The Pfizer Guide to Careers in Public Health is published by Pfizer Pharmaceuticals Group, Pfizer Inc. New York, NY copyright ©2002, 2003. All rights reserved. The contents do not necessarily reflect the views of Pfizer Inc. No part of this publi- cation may be reproduced in any form without prior written permission from the publisher.
    [Show full text]
  • Serotonin Model of Schizophrenia: Emerging Role of Glutamate Mechanisms 1
    Brain Research Reviews 31Ž. 2000 302±312 www.elsevier.comrlocaterbres Interactive report Serotonin model of schizophrenia: emerging role of glutamate mechanisms 1 George K. Aghajanian ), Gerard J. Marek Departments of Psychiatry and Pharmacology, Yale UniÕersity School of Medicine and the Connecticut Mental Health Center, 34 Park St., New HaÕen, CT 06508, USA Accepted 30 June 1999 Abstract The serotoninŽ. 5-HT hypothesis of schizophrenia arose from early studies on interactions between the hallucinogenic drug LSD Ž.D-lysergic acid diethylamide and 5-HT in peripheral systems. More recent studies have shown that the two major classes of psychedelic hallucinogens, the indoleaminesŽ. e.g., LSD and phenethylamines Ž e.g., mescaline . , produce their central effects through a common action upon 5-HT2 receptors. This review focuses on two brain regions, the locus coeruleus and the cerebral cortex, where the actions of indoleamine and the phenethylamine hallucinogens have been shown to be mediated by 5-HT2A receptors; in each case, the hallucinogens Ž.via 5-HT2A receptors have been found to enhance glutamatergic transmission. In the prefrontal cortex, 5-HT2A -receptors stimulation increases the release of glutamate, as indicated by a marked increase in the frequency of excitatory postsynaptic potentialsrcurrents Ž.EPSPsrEPSCs in the apical dendritic region of layer V pyramidal cells; this effect is blocked by inhibitory group IIrIII metabotropic glutamate agonists acting presynaptically and by an AMPArkainate glutamate antagonist, acting postsynaptically at non-NMDA glutamate receptors. A major alternative drug model of schizophrenia, previously believed to be entirely distinct from that of the psychedelic hallucinogens, is based on the psychotomimetic properties of antagonists of the NMDA subtype of glutamate receptorŽ e.g., phencylidine and ketamine.
    [Show full text]
  • Ketamine Psychedelic Psychotherapy: Focus on Its Pharmacology, Phenomenology, and Clinical Applications Eli Kolp Private Practice
    International Journal of Transpersonal Studies Volume 33 | Issue 2 Article 8 7-1-2014 Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications Eli Kolp Private Practice Harris L. Friedman University of Florida Evgeny Krupitsky St. Petersburg State Pavlov Medical University Karl Jansen Auckland Hospital Mark Sylvester Private Practice See next page for additional authors Follow this and additional works at: https://digitalcommons.ciis.edu/ijts-transpersonalstudies Part of the Philosophy Commons, Psychiatry and Psychology Commons, and the Religion Commons Recommended Citation Kolp, E., Friedman, H. L., Krupitsky, E., Jansen, K., Sylvester, M., Young, M. S., & Kolp, A. (2014). Kolp, E., Friedman, H. L., Krupitsky, E., Jansen, K., Sylvester, M., Young, M. S., & Kolp, A. (2014). Ketamine psychedelic psychotherapy: Focus on its pharmacology, phenomenology, and clinical applications. International Journal of Transpersonal Studies, 33(2), 84–140.. International Journal of Transpersonal Studies, 33 (2). http://dx.doi.org/10.24972/ijts.2014.33.2.84 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License. This Special Topic Article is brought to you for free and open access by the Journals and Newsletters at Digital Commons @ CIIS. It has been accepted for inclusion in International Journal of Transpersonal Studies by an authorized administrator of Digital Commons @ CIIS. For more information, please contact [email protected]. Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications Authors Eli Kolp, Harris L. Friedman, Evgeny Krupitsky, Karl Jansen, Mark Sylvester, M. Scott ounY g, and Anna Kolp This special topic article is available in International Journal of Transpersonal Studies: https://digitalcommons.ciis.edu/ijts- transpersonalstudies/vol33/iss2/8 Ketamine Psychedelic Psychotherapy: Focus on its Pharmacology, Phenomenology, and Clinical Applications Eli Kolp Harris L.
    [Show full text]
  • Chadi Abdallah, M.D. Associate Member Baylor College of Medicine
    Chadi Abdallah, M.D. Ted Abel, Ph.D. James Abelson, M.D.,Ph.D. Associate Member Fellow Member Emeritus Baylor College of Medicine University of Iowa, Carver College of University of Michigan Health System Medicine Anissa Abi-Dargham, M.D. Megumi Adachi, Ph.D. R. Alison Adcock, M.D.,Ph.D. Fellow Associate Member Associate Member Stony Brook University Astellas Research Institute of America Duke University LLC Nii Addy, Ph.D. Nika Adham, B.Sc.,M.Sc.,Ph.D. Bryon Adinoff, M.D. Associate Member Member Fellow Emeritus Yale University School of Medicine Abbvie University of Colorado Medical School Caleb Adler, M.D. Martin Adler, Ph.D. George Aghajanian, M.D. Member Fellow Emeritus Fellow Emeritus University of Cincinnati College of Temple University School of Medicine Yale University School of Medicine Medicine Bernard Agranoff, B.S.,M.D. Susanne Ahmari, M.D.,Ph.D. Katherine Aitchison, Fellow Emeritus Member B.A.,FRCPsych,Ph.D. University of Michigan University of Pittsburgh Member University of Alberta Howard Aizenstein, M.D.,Ph.D. Olusola Ajilore, M.D.,Ph.D. Schahram Akbarian, M.D.,Ph.D. Member Member Member University of Pittsburgh University of Illinois at Chicago Icahn School of Medicine At Mount Sinai Huda Akil, Ph.D. Martin Alda, FRCPC,M.D. Robert Alexander, M.D. Fellow Member Member University of Michigan Dalhousie University Takeda George Alexopoulos, M.D. Tanya Alim, M.D. Murray Alpert, Ph.D. Fellow Emeritus Member Fellow Emeritus Weill Cornell Medical College Howard University Larry Alphs, M.D.,Ph.D. C. Anthony Altar, Ph.D. Susan Amara, Ph.D.
    [Show full text]
  • Ronald Davis Is Currently a Partner at 21St Century Policing Solutions, LLC
    Ronald L. Davis _____________________________________________ Ronald L. Davis served in the Obama Administration as the Director of the United States De- partment of Justice (DOJ), Office of Community Oriented Policing Services (COPS Office) from 2013 to 2017. The COPS Office is responsible for advancing community policing nationwide and manages over $1.2 Billion in federal grants to support the community policing activities for approximately 18,000 local, state, and tribal law enforcement agencies. In December 2014, President Barack Obama appointed Director Davis to serve as the Execu- tive Director of the President’s Task Force on 21st Century Policing (Task Force). President Obama charged Director Davis and the Task Force with developing concrete recommendations to improve community trust in the police while enhancing public safety. The final report of the Task Force now serves as a foundational document in American policing. Prior to serving as COPS Director, Davis had a distinguished career in law enforcement serving over 8 years as Chief of Police of East Palo Alto (CA) and 20 years with the Oakland (CA) Police Department. Davis was recognized for his innovative community policing efforts and for work- ing collaboratively with the community to dramatically reduce crime and violence in a city once named as the murder capital of the United States. Davis served as a member of the prestigious Harvard University and National Institute of Jus- tice Executive Sessions on Policing and Public Safety, and as a policing expert for DOJ on several “pattern and practices” investigations and on two federal monitoring teams with over- sight of police-reform Agreements/Consent Decrees between the DOJ and the Washington, D.C., and Detroit Police Departments.
    [Show full text]
  • Neurotrophin & Synaptogenesis
    Neurotrophin & synaptogenesis Freddy Jeanneteau, Margarita Arango-Lievano, Moses Chao To cite this version: Freddy Jeanneteau, Margarita Arango-Lievano, Moses Chao. Neurotrophin & synaptogenesis. John Rubenstein; Pasko Rakic; Bin Chen; Kenneth Y. Kwan; Hollis T. Cline; Jessica Cardin. Synapse Development and Maturation (2nd edition), Elsevier, pp.167-192, 2020, 978-0-12-823672-7. 10.1016/B978-0-12-823672-7.00007-7. hal-02922106 HAL Id: hal-02922106 https://hal.archives-ouvertes.fr/hal-02922106 Submitted on 25 Aug 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Chapter Neurotrophin & synaptogenesis Freddy Jeanneteau1, Margarita Arango-Lievano1 & Moses V. Chao 2 1. Institut de genomique fonctionelle, departments of Physiology, Neuroscience, Inserm, CNRS, University of Montpellier, Monpellier, France 2. Skirball Institute of Biomolecular Medicine, Departments of Cell Biology, Physiology & Neuroscience and Psychiatry, New York University Langone Medical Center, 540 First Avenue, New York, NY 10016, USA Correspondence: Email: [email protected] ; [email protected] 1 Outline. Summary I. Introduction II. One neurotrophin, three ligands at the synapse II.1. Pro-BDNF II.2. Cleavage of Pro-BDNF II.3. The prodomain III. Which side of the synapse produce neurotrophins? III.1.
    [Show full text]
  • AN ORAL HISTORY of NEUROPSYCHOPHARMACOLOGY the FIRST FIFTY YEARS Peer Interviews
    AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Volume Two: Neurophysiology Copyright © 2011 ACNP Thomas A. Ban (series editor) AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY Max Fink (volume editor) VOLUME 2: Neurophysiology All rights reserved. No part of this book may be used or reproduced in any manner without written permission from the American College of Neuropsychopharmacology (ACNP). Library of Congress Cataloging-in-Publication Data Thomas A. Ban, Max Fink (eds): An Oral History of Neuropsychopharmacology: The First Fifty Years, Peer Interviews Includes bibliographical references and index ISBN: 1461161452 ISBN-13: 9781461161455 1. Electroencephalography and neurophysiology 2. Pharmaco-EEG 3. Sleep EEG 4. Cerebral blood flow 5. Brain metabolism 6. Brain imaging Publisher: ACNP ACNP Executive Office 5034A Thoroughbred Lane Brentwood, Tennessee 37027 U.S.A. Email: [email protected] Website: www.acnp.org Cover design by Jessie Blackwell; JBlackwell Design www.jblackwelldesign.com AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY AN ORAL HISTORY OF NEUROPSYCHOPHARMACOLOGY THE FIRST FIFTY YEARS Peer Interviews Edited by Thomas A. Ban Co-editors Volume 1: Starting Up - Edward Shorter Volume 2: Neurophysiology - Max Fink Volume 3: Neuropharmacology - Fridolin Sulser Volume 4: Psychopharmacology - Jerome Levine Volume 5: Neuropsychopharmacology - Samuel Gershon Volume 6: Addiction - Herbert D. Kleber Volume 7: Special Areas - Barry Blackwell Volume 8: Diverse Topics - Carl Salzman Volume 9: Update - Barry Blackwell Volume 10: History of the ACNP - Martin M. Katz VOLUME 2 NEUROPHYSIOLOGY ACNP 2011 VOLUME 2 Max Fink NEUROPHYSIOLOGY Preface Thomas A. Ban Dedicated to the Memory of Jonathan O. Cole, President ACNP, 1966 PREFACE Thomas A. Ban In Volume 1 of this series, 22 clinicians and basic scientists reflected on their contributions to the “starting up” of neuropsychopharmacology (NPP).
    [Show full text]